Alkermes has released long term data for its OX2R agonist which could face two other drugs of the same mechanism of action on the market.
The pharmaceutical and healthcare sector has always been information-rich. From clinical trial data and regulatory submissions to scientific literature and market intelligence, professionals depend on high-quality published STM content every...
The pharmaceutical industry continues to be a hotbed of innovation, with activity driven by the evolution of new treatment paradigms,...
Combine proprietary data, human expertise, and purpose-built AI to uncover insights and accelerate better business decisions.
Discover our solutions
Pharma Technology Focus is our digital magazine, free to read online on all devices. Click the magazine cover to read the latest issue. You can subscribe for free to have each new issue delivered to your inbox.
How wearables can unlock their full potential in clinical research
Clinical trial experts cite trust and regulatory uncertainty as AI barriers
Kidney disease risk higher after Covid infection than after influenza infection
CinnaGen Enters EU Market with EMA Approval for Zandoriah®